相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Critical role for reactive oxygen species in apoptosis induction and cell migration inhibition by diallyl trisulfide, a cancer chemopreventive component of garlic
Kumar Chandra-Kuntal et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
The Prolyl Isomerase Pin1 Acts Synergistically with CDK2 to Regulate the Basal Activity of Estrogen Receptor α in Breast Cancer
Chiara Lucchetti et al.
PLOS ONE (2013)
Diallyl trisulfide induces apoptosis in human breast cancer cells through ROS-mediated activation of JNK and AP-1
Hye-Kyung Na et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Diallyl trisulfide as an inhibitor of benzo(a)pyrene-induced precancerous carcinogenesis in MCF-10A cells
Yasmeen M. Nkrumah-Elie et al.
FOOD AND CHEMICAL TOXICOLOGY (2012)
D,L-sulforaphane-induced apoptosis in human breast cancer cells is regulated by the adapter protein p66Shc
Kozue Sakao et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Regulation of Estrogen Receptor alpha N-Terminus Conformation and Function by Peptidyl Prolyl Isomerase Pin1
Prashant Rajbhandari et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease
Tae Ho Lee et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2011)
Role of Bim in Diallyl Trisulfide-Induced Cytotoxicity in Human Cancer Cells
Byeong-Chel Lee et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Withaferin A Suppresses Estrogen Receptor-α Expression in Human Breast Cancer Cells
Eun-Ryeong Hahm et al.
MOLECULAR CARCINOGENESIS (2011)
Progress in endocrine approaches to the treatment and prevention of breast cancer
Ifeyinwa Obiorah et al.
MATURITAS (2011)
Garlic constituent diallyl trisulfide induced apoptosis in MCF7 human breast cancer cells
Ahmed Malki et al.
CANCER BIOLOGY & THERAPY (2009)
Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells
Mi Ra Kim et al.
CANCER SCIENCE (2009)
Genomic actions of estrogen receptor alpha: what are the targets and how are they regulated?
Willem-Jan Welboren et al.
ENDOCRINE-RELATED CANCER (2009)
The potential role of estrogen receptors and the SRC family as targets for the treatment of breast cancer
Melanie Spears et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Garlic Constituent Diallyl Trisulfide Prevents Development of Poorly Differentiated Prostate Cancer and Pulmonary Metastasis Multiplicity in TRAMP Mice
Shivendra V. Singh et al.
CANCER RESEARCH (2008)
Estrogen receptor α mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death
Meihua Sui et al.
CANCER RESEARCH (2007)
Molecular targets of cancer chemoprevention by garlic-derived organosulfides
Anna Herman-Antosiewicz et al.
ACTA PHARMACOLOGICA SINICA (2007)
Diallyl trisulfide suppresses growth of PC-3 human prostate cancer xenograft in vivo in association with Bax and Bak induction
Dong Xiao et al.
CLINICAL CANCER RESEARCH (2006)
Determination of the concentration of diallyl trisulfide in rat whole blood using gas chromatography with electron-capture detection and identification of its major metabolite with gas chromatography mass spectrometry
Xuehui Sun et al.
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2006)
Attenuation of estrogen receptor α (ERα) signaling by selenium in breast cancer cells via downregulation of ERα gene expression
YM Shah et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2
D Xiao et al.
ONCOGENE (2004)
Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: Insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype
J Frasor et al.
ENDOCRINOLOGY (2003)
Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits proliferation of human prostate cancer cells by causing G2/M arrest and inducing apoptosis
D Xiao et al.
CARCINOGENESIS (2003)
Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial
JA Cauley et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
分享论文
